Safety of lipid emulsion in very low-birthweight infants according to cytokine level

Background The aim of this study was to verify whether lipid emulsion treatment aggravates infection and inflammation in very low‐birthweight (VLBW) infants. Study design Very low‐birthweight (

Saved in:
Bibliographic Details
Published in:Pediatrics international 2016-07, Vol.58 (7), p.556-561
Main Authors: Ichikawa, Junko, Ichikawa, Go, Tsuboi, Yayoi, Kuribayashi, Ryota, Watabe, Yoshiyuki, Sairenchi, Toshimi, Suzumura, Hiroshi, Arisaka, Osamu
Format: Article
Language:English
Subjects:
Bilirubin
Birth weight
cytokine
Cytokines
Cytokines - blood
Emulsions
Fat Emulsions, Intravenous - administration & dosage
Female
Follow-Up Studies
Gestational Age
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases - blood
Infant, Premature, Diseases - drug therapy
Infant, Very Low Birth Weight
Infants
Inflammation
Insulin
Intellectual development
Light therapy
lipid emulsion
Lipids
Male
Monocyte chemoattractant protein 1
Monocytes
nutrition
Oils & fats
Oxygen
Parenteral Nutrition - methods
Pediatrics
Phototherapy
postnatal growth restriction
Retrospective Studies
Safety engineering
Soybean oil
Treatment Outcome
Tumor necrosis factor
Tumor necrosis factor-TNF
very low-birthweight
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The aim of this study was to verify whether lipid emulsion treatment aggravates infection and inflammation in very low‐birthweight (VLBW) infants. Study design Very low‐birthweight (
ISSN:1328-8067
1442-200X
DOI:10.1111/ped.12871